III Viamed–FutureMeds Conference | Innovation with Purpose: Patients and Data Transforming Clinical Research
Home News III Viamed–FutureMeds Conference | Innovation with Purpose: Patients and Data Transforming Clinical Research

III Viamed–FutureMeds Conference | Innovation with Purpose: Patients and Data Transforming Clinical Research

APRIL 24, 2026 Events of the ecosystem

The 3rd Viamed–FutureMeds Conference brings together experts, institutions and professionals committed to a common mission: transforming the way patients participate in clinical research. At a time when innovation, real‐world data and artificial intelligence are redefining recruitment and engagement models, this conference aims to create a space for reflection and collaboration that will enable progress toward more efficient, inclusive and people‐centred trials. 

The conference aims to explore, share and consolidate innovative patient engagement strategies, integrating the patient’s voice throughout the clinical trial and analyzing how artificial intelligence and real‐world data can improve the efficiency, quality and impact of clinical research in Spain. 

Martes 12 de Mayo 2026. From 09:00 to 17:00 h

Edificio CEU, Aula Magna

C/Julián Romea, 23 – Madrid

SIGN UP HERE: https://jornadaviamedfuturemed26s.eventbrite.es

 

PROGRAMME 

9.00 - Registration and welcome coffee 

10.00 - Opening ceremony 

Rosa María Visiedo Claverol, Rector of Universidad CEU San Pablo. 

Inmaculada Ibañez de Cáceres, Director of Teaching and Research at the Regional Ministry of Health of the Comunidad de Madrid.

10.30 - Challenges and Opportunities in the Future of Clinical Research 

Anna Sala Cunill, Head of the Innovation Unit at Vall D’Hebron Hospital. Specialist in allergology, Doctor of Medicine. Co-founder and Medical Director of anAPPhylaxis. 

11.30 - The Patient Perspective: perceptions and experiences in clinical research 

Annick de Bruin. Chief Research and Insights Officer. Research Services. Center for Information & Study on Clinical Research Participation (CISCRP), USA.

12.15 - Roundtable: Patient Engagement 360o: innovating practice with new models and real experiences 

 

Session Chair: Rocío Díaz Sánchez. Managing Director - FutureMeds Spain. Annick de Bruin. Chief Research and Insights Officer. Research Services Center 

for Information & Study on Clinical Research Participation (CISCRP), USA. 

Carmen Yélamos. National Coordinator of Psychological Care Programmes Asociación Española Contra el Cáncer (AECC), Spain. 

Arkadiusz Kasperski. Head of Patient Engagement – FutureMeds Poland. 

13.15 - Networking Lunch: connections that drive research 

14.30 - Opportunities and challenges of real-world data and artificial Intelligence to accelerate clinical research 

David Pérez del Rey. Professor of Artificial Intelligence at Universidad Politécnica de Madrid (UPM). Director of the TriNetX–UPM Data Integration Partnership. 

15.30 - Keynote speech: Clinical Research 2026–2030: Patient Engagement, EHDS, RWD and AI as levers for the future 

Amelia Martin Uranga. Director of the Clinical and Translational Research Department and Head of the Innovative Medicines Platform at Farmaindustria. 

16.30 - Conclusions and Closing Remarks 

Radoslaw Janiak. CEO FutureMeds.
Paulo Gonçalves. CEO Grupo Viamed Salud.

November 20, 2026 Members' News
SMED Clinical Research joins the Barcelona & Madrid Health Hub
Joining Barcelona & Madrid Health Hub marks an important step for SMED Clinical Research as the company continues to strengthen its presence within the healthcare and life sciences ecosystem. It creates new opportunities to stay close to innovation, collaborate with leading organisations, and better understand the evolving needs of sponsors, clinical sites and the patients they serve.
Read more
November 19, 2026 Members' News
Partner Insights 2026: Technology, Innovation and Collaboration in Life Sciences
Ambit Iberia has launched Partner Insights 2026, the new edition of its annual magazine bringing together the perspectives of 13 technology partners on the trends, challenges and opportunities shaping the future of the Life Sciences industry.
Read more
November 19, 2026 Members' News
Artificial Intelligence comes to informed consent to answer patients’ questions before surgery
Informed consent is a routine process in any hospital, but its management continues to generate costs, administrative workload and traceability issues when carried out on paper. To address these challenges, ASHO has developed a new end-to-end informed consent management platform that digitizes the entire process and gives patients a more active role, allowing them to access the information in advance, resolve their questions before signing and arrive at surgery with a better understanding of the procedure.
Read more
November 18, 2026 Members' News
Corporate Nutrition for Every Type of Work. The Great Blind Spot in Workplace Wellness
Do we really take care of all the factors that influence team well-being? In recent years, companies have made progress in mental health, work-life balance, flexibility, and creating healthier work environments. However, there is one element that often remains outside the strategy or is treated in a merely informative way: nutrition during the workday.
Read more
November 17, 2026 Events of the ecosystem
Madrid Health Hub leads the conversation at Horizon Deep Tech Summit
On November 12th, Madrid Health Hub brought together experts from Eurecat, Bitsphi and Clave Capital at Horizon Deep Tech Summit 2026 to explore how healthcare ecosystems can accelerate innovation.  
Read more
November 16, 2026 Members' News
M2H brings exercise prescription into Primary Care: doctors and exercise specialists, finally on a single digital layer
The Barcelona-based healthtech startup, a new member of Barcelona & Madrid Health Hub, connects family doctors and Physical Exercise Specialists within the same clinical workflow, keeping full patient traceability.
Read more
November 13, 2026 Members' News
The Ultimate Guide for Choosing an Enterprise CMS
In strictly regulated industries like pharmaceutical and health insurance, delivering seamless, compliant digital experiences—from patient portals to provider resources—is critical. Magnolia is a leading composable Digital Experience Platform (DXP) trusted by healthcare and global enterprise giants like Sanofi and Generali. By centralizing websites, portals, and apps into one intuitive, open platform, Magnolia's CMS empowers IT teams to build freely and marketing teams to launch faster—all while protecting brand integrity and compliance.
Read more
November 13, 2026 Members' News
Fund It, Build It, Certify It: A MedTech Startup's Roadmap to Market
Most MedTech startups don't stall because the technology fails. They stall because funding and regulation were planned separately. Under MDR, compliance is not the last step before submission. It shapes your product and company decisions from day one. And investors know it: before a Series A or B, they expect a credible regulatory strategy, not just a promising prototype. That's why, QbD Group and Capital Cell teamed up, to bring both sides together in one free webinar live session.
Read more
November 12, 2026 Members' News
Health Tech Enterprise launches half-price UK market entry offer for Barcelona & Madrid Health Hub members
Health Tech Enterprise introduces an exclusive UK Market Entry Pathfinder offer for Barcelona & Madrid Health Hub members, helping MedTech companies assess their readiness for UK expansion and receive an evidence-based market entry recommendation within 21 days, with preferential member pricing available until 31 December 2026.
Read more
November 12, 2026 Members' News
Your Next Innovation May Already Exist
Connecting business challenges with scientific knowledge
Read more